Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 12218327

Decrease in urinary excretion of aquaporin-2 associated with impaired urinary concentrating ability in diabetic nephropathy.

Tomoatsu Nakamura·Takako Saito·Ikuyo Kusaka·Minori Higashiyama·Shoichiro Nagasaka·Shun Ishibashi·San-e Ishikawa
View original source ↗Export metadata ↓

Abstract

Aquaporin-2 (AQP-2) is known to be expressed in the renal collecting duct cells and participates in urinary concentration in response to arginine vasopressin (AVP). The present study was undertaken to determine whether progression of renal dysfunction affects urinary excretion of AQP-2 in diabetic nephropathy. The study was composed of 8 control subjects and 14 patients with type 2 diabetes classified into two groups according to serum creatinine level (cut-off point; 1.5 mg/dl). After an 8-hour water deprivation, both urinary osmolality (U(osm)) and urinary excretion of AQP-2 significantly decreased in the diabetic patients with chronic renal failure as compared to the control subjects (p < 0.0001, p < 0.05, respectively). After a water load (10 ml/kg), no differences were found in plasma osmolality (P(osm)), AVP levels and U(osm), whereas urinary excretion of AQP-2 significantly decreased in the patients with chronic renal failure as compared to the control subjects (p < 0.05). These results indicate that the decreased urinary excretion of AQP-2 in diabetic nephropathy is due to the impaired cellular signaling of AVP in collecting duct cells, which may be partly involved in the urinary concentrating defect in renal failure.

Explore related subjects

Aquaporin 2Aquaporin 6AquaporinsArginine VasopressinCase-Control StudiesDiabetic NephropathiesHumansKidney Concentrating AbilityKidney Tubules, CollectingMiddle AgedSignal TransductionJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tomoatsu Nakamura, Takako Saito, Ikuyo Kusaka, Minori Higashiyama, Shoichiro Nagasaka, Shun Ishibashi, San-e Ishikawa. 2002. Decrease in urinary excretion of aquaporin-2 associated with impaired urinary concentrating ability in diabetic nephropathy.. https://doi.org/10.1159/000063285

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Expression of aquaporin 2 in human endometrium.

OBJECTIVE: To study the expression of aquaporin-2 (AQP2) in human endometrium. DESIGN: Prospective clinical study. SETTING: Hospital-based unit for gynecology and obstetrics and research laboratories. PATIENT(S): Healthy women with proven fertility who were divided into four groups according to LH peak. INTERVENTION(S): Endometrial biopsies were obtained from 34 women on cycle days LH+4 to LH+14. MAIN OUTCOME MEASURE(S): Localization of AQP2 in human endometrium during normal cycle using immunohistochemistry, verification of AQP2 expression through detection of AQP2 mRNA in reverse transcriptase-polymerase chain reaction (RT-PCR), detection of pinopodes using scanning electron microscopy, and confirmation of AQP2 on pinopodes in confocal microscopy. RESULT(S): Immunostaining of AQP2 is present in the luminal and glandular epithelium but not in the stroma. Some vessels stained positive for AQP2. When present, pinopodes stained positive, which was confirmed using confocal microscopy. A significant increase in staining intensity was seen in the glandular and luminal epithelium during the mid and late luteal phases of the cycle. The presence of AQP2 in human endometrium was also confirmed by RT-PCR. CONCLUSION(S): AQP2 is present in the human endometrium. The expression of AQP2 appears to be cycle dependent and suggests a role for AQP2 in implantation, edema, and/or menstruation.

Aquaporin 2↗
PubMed2006

Aquaporin-2 excretion and renal function during the 1st week of life in preterm newborn infants.

In many preterm infants, a characteristic pattern of fluid and electrolyte homeostasis occurs during the 1st week of life, consisting of three phases: prediuretic, diuretic, and postdiuretic. In this study, we evaluated the possible role of aquaporin-2 (AQP2) in renal concentrating ability and correlated it with other markers of the renal function in healthy preterm infants. Daily urine and spot blood samples were collected from 9 healthy preterm (32 +/- 1 weeks) infants at postnatal ages 1, 3, and 7 days. Urine and serum osmolality, creatinine, electrolytes, and AQP2 excretion were measured. All infants showed a significant (about 7%) weight loss on day 3 associated with a more than threefold increase in urine output without a significant change in fluid intake (diuretic phase). The creatinine clearance increased on day 3, indicating an increase in glomerular filtration rate. Interestingly, on day 3, the level of total excreted AQP2 (pmol/h) was significantly higher when compared to day 1 and day 7, and the same tendency was observed for urine osmolality. To conclude, the observed increase in urine osmolality and creatinine clearance during the diuretic phase, paralleled by an increase in total AQP2 excretion, suggests that AQP2 can contribute to the urinary concentrating ability early in postnatal life.

Aquaporin 2↗
PubMed2006

Urinary aquaporin-2 excretion during early human development.

This study was undertaken to assess one of the determinants of kidney concentrating capacity, aquaporin-2 (AQP2), in order to understand the physiopathology of water balance in newborn babies. Urinary AQP2 excretion has been shown to be proportional to AQP2 level in the apical plasma membrane of the kidney collecting ducts and has been suggested as a marker of vasopressin (AVP) action. Urinary AQP2 excretion in the early postnatal period and at 3 weeks of age was measured in 123 neonates admitted during a 6-month period to the neonatal intensive care unit of the Children's Hospital of Toulouse, France. Clinical and biochemical data were collected for each child. During the first days after birth, higher urinary AQP2 was observed in boys than in girls (P=0.01) and positively correlated with urinary sodium/potassium (Na/K) ratio (r=0.33, P=0.01). When the babies had reached 3 weeks of age, urinary AQP2 was proportional to the gestational age at birth (r=0.33, P=0.0068) and daily weight gain (r=0.36, P=0.003). It did not correlate with urinary osmolality, which was overall very low in all babies. Urinary AQP2 was decreased in conditions of impaired renal function (r=-0.42, P=0.0005) and acidosis (P=0.03). Prenatal corticosteroid treatment had no significant impact on urinary AQP2 level. Our data show that urinary AQP2 correlates with the overall maturity of tubular function in human neonates. In babies at this early age, urinary AQP2 cannot serve as a direct marker of the renal action of AVP but reflects AQP2 expression level associated with different physiopathological conditions.

Aquaporin 2↗